Value through Innovation27 July 2016

Clinical Study Results

  • BOXAGRIPPAL ® - Healthy
    Clinical Study Number 1024.9
    Study Indication Healthy
    Product BOXAGRIPPAL ®
    Generic Name Ibuprofen + Pseudoephedrine
    Lab Code
    Clinical Phase I
    Study Title

    Bioequivalence of a fixed dose combination tablet containing 400 mg Ibuprofen and 60 mg Pseudoephedrine-HCl compared to two film coated fixed dose combination tablets RhinAdvil® (200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) administered in at least 48 healthy male and female subjects (Open-label, randomised, laboratory blind, single dose, two-way crossover, Phase I trial).

    Study Document Trial synopsis 1024.9 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.